CD4 and neoplasm: Whole tumor antigens, as opposed to defined tumor-derived peptides and proteins, could represent the ideal source for pulsing DCs as they contain a vast array of immunogenic epitopes to activate both CD4+ and CD8+ tumor-specific T cells to prevent tumor escape.